{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "2021", "item": "https://www.patentleaderboard.com/2021/"}, {"@type": "ListItem", "position": 3, "name": "Hoffmann-La Roche", "item": "https://www.patentleaderboard.com/2021/company/hoffmann-la-roche"}, {"@type": "ListItem", "position": 4, "name": "Tilman Schlothauer", "item": "https://www.patentleaderboard.com/2021/inventor/fl:ti_ln:schlothauer-3"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
TS

Tilman Schlothauer — 3 Patents in 2021

Hoffmann-La Roche: 3 patents #27 of 319Top 9%
Penzberg, DE: #6 of 59 inventorsTop 15%
Overall (2021): #59,972 of 548,734Top 15%
3 Patents 2021

Issued Patents 2021

Showing 1–3 of 3 patents

Patent #TitleCo-InventorsDate
11130810 Bispecific antibodies specific for PD1 and TIM3 Laura Codarri-Deak, Georg Fertig, Jens Fischer, Christian Klein, Viktor Levitski +7 more 2021-09-28
11091541 Human FcRn-binding modified antibodies and methods of use Guido Hartmann, Joerg Thomas Regula, Matthias Rueth, Wolfgang Schaefer 2021-08-17
10899846 Fc-region variants with modified FcRn- and protein A-binding properties 2021-01-26